Table 1.
Patients (N = 372) |
|
---|---|
Age (years) mean (SD), range | 79.4 (8.9), 53–102 |
Sex (female), n (%) | 283 (76.1) |
Type of fracture, n (%) | |
Pertrochanteric | 191 (51.3) |
Intracapsular | 151 (40.6) |
Subtrochanteric | 24 (6.4) |
Others | 6 (1.6) |
Identification of patients, n (%) | |
Emergency registry | 217 (58.3) |
Admission | 129 (34.6) |
Rheumatology osteoporosis clinic | 26 (6.9) |
Previous treatment with bisphosphonates, n (%)a | 53 (14.4) |
Risk factors for fracture, n (%) | |
Previous fragility fracture | 76 (20.4) |
Parental hip fracture | 35 (9.4) |
Smoking | 37 (9.9) |
Corticosteroids | 40 (10.7) |
Rheumatoid arthritis | 10 (2.7) |
Secondary osteoporosis | 59 (15.8) |
Alcohol | 17 (4.6) |
Densitometry results, n (%)a | |
Normal | 11 (5.3) |
Osteopenia | 81 (39.1) |
Osteoporosis | 115 (55.5) |
T score lumbar spine, mean (SD) | − 1.9 (1.6) |
T score femoral neck, mean (SD) | − 2.4 (1.0) |
FRAX | |
FRAX major, mean (SD) | 18.4 (10.2) |
FRAX hip, mean (SD) | 9.7 (8.2) |
Referral after baseline visit, n (%)a | |
Rheumatology osteoporosis clinic | 57 (15.3) |
Primary care | 315 (84.7) |
aPrevious treatment recorded in 369 patients. Densitometry values were recorded in 207 patients.